Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE7A | Q13946 | 3/20 | 0.39 |
| ▸ | GSK3A | P49840 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | MGLL | Q99685 | 1/20 | 0.37 |
| ▸ | P2RX4 | Q99571 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 2/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.33 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | SYK | P43405 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15434758 | 0.78 | TDP1 (0.40) | PDE7AP2RX4ALDH1A1TDP1POLB | |
| SCHEMBL30389896 | 0.77 | DUSP3 (0.40) | PDE7AALDH1A1HPGD | |
| SCHEMBL25221531 | 0.77 | DUSP3 (0.40) | PDE7AALDH1A1HPGD | |
| SCHEMBL25241214 | 0.75 | KDM4E (0.41) | P2RX4ALDH1A1GLAHPGD | |
| SCHEMBL21148082 | 0.75 | KDM4E (0.42) | PDE7AALDH1A1TDP1POLBHPGD | |
| SCHEMBL25277587 | 0.74 | KDM4E (0.42) | PDE7AGSK3AGSK3BMGLLALDH1A1 | |
| SCHEMBL28351422 | 0.74 | KDM4E (0.48) | P2RX4ALDH1A1POLBGLAHPGD | |
| SCHEMBL23308373 | 0.73 | HCRTR1 (0.49) | ALDH1A1TDP1GLAHCRTR1HPGD | |
| SCHEMBL782631 | 0.73 | ALDH1A1 (0.50) | PDE7AGSK3AGSK3BMGLLALDH1A1 | |
| SCHEMBL29521714 | 0.73 | ALDH1A1 (0.50) | PDE7AGSK3AGSK3BMGLLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2872589-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-07-26 | — | — | EP | disclosed |
| US-20150295186-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2015-10-15 | — | — | US | disclosed |
| US-20150295186-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2015-10-15 | — | — | US | disclosed |
| WO-2014008967-A2 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2014-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150295186-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | L1CAM, EPCAM, OR10J3 | PDE7A 4734/4885GSK3A 3955/4885GSK3B 4050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.